Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Comparison of human isogeneic Wharton's jelly MSCs and iPSC-derived MSCs reveals differentiation-dependent metabolic responses to IFNG stimulation.

Devito L, Klontzas ME, Cvoro A, Galleu A, Simon M, Hobbs C, Dazzi F, Mantalaris A, Khalaf Y, Ilic D.

Cell Death Dis. 2019 Mar 20;10(4):277. doi: 10.1038/s41419-019-1498-0.

2.

Apoptotic mesenchymal stromal cells induce prostaglandin E2 in monocytes: implications for the monitoring of mesenchymal stromal cells activity.

Cheung TS, Galleu A, von Bonin M, Bornhäuser M, Dazzi F.

Haematologica. 2019 Mar 7. pii: haematol.2018.214767. doi: 10.3324/haematol.2018.214767. [Epub ahead of print]

3.

Mesenchymal stromal cells for acute graft-versus-host disease: response at 1 week predicts probability of survival.

Galleu A, Milojkovic D, Deplano S, Szydlo R, Loaiza S, Wynn R, Marks DI, Richardson D, Orchard K, Kanfer E, Tholouli E, Saif M, Sivaprakasam P, Lawson S, Bloor A, Pagliuca A, Potter V, Mehra V, Snowden JA, Vora A, Kishore B, Hunter H, Apperley JF, Dazzi F.

Br J Haematol. 2019 Apr;185(1):89-92. doi: 10.1111/bjh.15749. Epub 2019 Jan 13.

4.

Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation.

Trento C, Bernardo ME, Nagler A, Kuçi S, Bornhäuser M, Köhl U, Strunk D, Galleu A, Sanchez-Guijo F, Gaipa G, Introna M, Bukauskas A, Le Blanc K, Apperley J, Roelofs H, Van Campenhout A, Beguin Y, Kuball J, Lazzari L, Avanzini MA, Fibbe W, Chabannon C, Bonini C, Dazzi F.

Biol Blood Marrow Transplant. 2018 Nov;24(11):2365-2370. doi: 10.1016/j.bbmt.2018.07.015. Epub 2018 Jul 20.

5.

Effects of maternal obesity on Wharton's Jelly mesenchymal stromal cells.

Badraiq H, Cvoro A, Galleu A, Simon M, Miere C, Hobbs C, Schulz R, Siow R, Dazzi F, Ilic D.

Sci Rep. 2017 Dec 14;7(1):17595. doi: 10.1038/s41598-017-18034-1.

6.

Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation.

Galleu A, Riffo-Vasquez Y, Trento C, Lomas C, Dolcetti L, Cheung TS, von Bonin M, Barbieri L, Halai K, Ward S, Weng L, Chakraverty R, Lombardi G, Watt FM, Orchard K, Marks DI, Apperley J, Bornhauser M, Walczak H, Bennett C, Dazzi F.

Sci Transl Med. 2017 Nov 15;9(416). pii: eaam7828. doi: 10.1126/scitranslmed.aam7828.

7.

Bone marrow mesenchymal stromal cells induce nitric oxide synthase-dependent differentiation of CD11b+ cells that expedite hematopoietic recovery.

Trento C, Marigo I, Pievani A, Galleu A, Dolcetti L, Wang CY, Serafini M, Bronte V, Dazzi F.

Haematologica. 2017 May;102(5):818-825. doi: 10.3324/haematol.2016.155390. Epub 2017 Feb 9.

8.

A genome-wide association study by ImmunoChip reveals potential modifiers in myelodysplastic syndromes.

Danjou F, Fozza C, Zoledziewska M, Mulas A, Corda G, Contini S, Dore F, Galleu A, Di Tucci AA, Caocci G, Gaviano E, Latte G, Gabbas A, Casula P, Delogu LG, La Nasa G, Angelucci E, Cucca F, Longinotti M.

Exp Hematol. 2016 Nov;44(11):1034-1038. doi: 10.1016/j.exphem.2016.07.005. Epub 2016 Jul 21.

PMID:
27449989
9.

Rapid and Efficient Stable Gene Transfer to Mesenchymal Stromal Cells Using a Modified Foamy Virus Vector.

Sweeney NP, Regan C, Liu J, Galleu A, Dazzi F, Lindemann D, Rupar CA, McClure MO.

Mol Ther. 2016 Aug;24(7):1227-36. doi: 10.1038/mt.2016.91. Epub 2016 May 2.

10.

Enhancement of the immunoregulatory potency of mesenchymal stromal cells by treatment with immunosuppressive drugs.

Girdlestone J, Pido-Lopez J, Srivastava S, Chai J, Leaver N, Galleu A, Lombardi G, Navarrete CV.

Cytotherapy. 2015 Sep;17(9):1188-99. doi: 10.1016/j.jcyt.2015.05.009.

11.

Azacitidine improves the T-cell repertoire in patients with myelodysplastic syndromes and acute myeloid leukemia with multilineage dysplasia.

Fozza C, Corda G, Barraqueddu F, Virdis P, Contini S, Galleu A, Isoni A, Dore F, Angelucci E, Longinotti M.

Leuk Res. 2015 Sep;39(9):957-63. doi: 10.1016/j.leukres.2015.06.007. Epub 2015 Jun 26.

PMID:
26209197
12.

Wharton's jelly mesenchymal stromal/stem cells derived under chemically defined animal product-free low oxygen conditions are rich in MSCA-1(+) subpopulation.

Devito L, Badraiq H, Galleu A, Taheem DK, Codognotto S, Siow R, Khalaf Y, Briley A, Shennan A, Poston L, McGrath J, Gentleman E, Dazzi F, Ilic D.

Regen Med. 2014;9(6):723-32. doi: 10.2217/rme.14.60.

PMID:
25431909
13.

Derangement of the T-cell repertoire in patients with B-cell non-Hodgkin's lymphoma.

Fozza C, Corda G, Virdis P, Contini S, Barraqueddu F, Galleu A, Isoni A, Cossu A, Dore F, Careddu MG, Bonfigli S, Giannico B, Longinotti M.

Eur J Haematol. 2015 Apr;94(4):298-309. doi: 10.1111/ejh.12417. Epub 2014 Aug 22.

PMID:
25040028
14.

Patients with early-stage myelodysplastic syndromes show increased frequency of CD4+CD25+CD127(low) regulatory T cells.

Fozza C, Longu F, Contini S, Galleu A, Virdis P, Bonfigli S, Murineddu M, Gabbas A, Longinotti M.

Acta Haematol. 2012;128(3):178-82. Epub 2012 Aug 10.

PMID:
22890368
15.

CD4+ and CD8+ T-cell skewness in classic Kaposi sarcoma.

Galleu A, Fozza C, Simula MP, Contini S, Virdis P, Corda G, Pardini S, Cottoni F, Pruneddu S, Angeloni A, Ceccarelli S, Longinotti M.

Neoplasia. 2012 Jun;14(6):487-94.

16.

T-cell receptor repertoire analysis in monozygotic twins concordant and discordant for type 1 diabetes.

Fozza C, Contini S, Corda G, Virdis P, Galleu A, Bonfigli S, Pacifico A, Maioli M, Mastinu F, Pitzalis M, Cucca F, Longinotti M.

Immunobiology. 2012 Sep;217(9):920-5. doi: 10.1016/j.imbio.2012.01.002. Epub 2012 Jan 4.

PMID:
22341303
17.

TCRBV20S1 polymorphism does not influence the susceptibility to type 1 diabetes and multiple sclerosis in the Sardinian population.

Fozza C, Zoledzieska M, Pitzalis M, Simula MP, Galleu A, Contini S, Bonfigli S, Cucca F, Longinotti M.

Immunogenetics. 2012 Feb;64(2):153-4. doi: 10.1007/s00251-011-0575-z. Epub 2011 Sep 17.

PMID:
21927869
18.

Patients with myelodysplastic syndromes show reduced frequencies of CD4(+) CD8(+) double-positive T cells.

Fozza C, Contini S, Virdis P, Galleu A, Massa A, Bonfigli S, Longinotti M.

Eur J Haematol. 2012 Jan;88(1):89-90. doi: 10.1111/j.1600-0609.2011.01708.x. Epub 2011 Nov 15. No abstract available.

PMID:
21919970
19.

Keratitis-Ichthyosis-Deafness Syndrome, Atypical Connexin GJB2 Gene Mutation, and Peripheral T-Cell Lymphoma: More Than a Random Association?

Fozza C, Poddie F, Contini S, Galleu A, Cottoni F, Longinotti M, Cucca F.

Case Rep Hematol. 2011;2011:848461. doi: 10.1155/2011/848461. Epub 2011 Aug 10.

20.

Efficacy of rituximab in autoimmune hemolytic anemia associated with splenic marginal zone lymphoma.

Fozza C, Galleu A, Careddu MG, Giannico DB, Bonfigli S, Contini S, Longinotti M.

Ann Hematol. 2010 Jan;89(1):133-4. doi: 10.1007/s00277-009-0782-y. Epub 2009 Jul 4. No abstract available.

PMID:
19578848
21.

Patients with myelodysplastic syndromes display several T-cell expansions, which are mostly polyclonal in the CD4(+) subset and oligoclonal in the CD8(+) subset.

Fozza C, Contini S, Galleu A, Simula MP, Virdis P, Bonfigli S, Longinotti M.

Exp Hematol. 2009 Aug;37(8):947-55. doi: 10.1016/j.exphem.2009.04.009. Epub 2009 May 4.

PMID:
19409953

Supplemental Content

Loading ...
Support Center